• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Transcriptional control in flies

Transcriptional control in flies

Transcriptional control in flies

Published on 11 May, 2010

“In a paper recently published in Genome Biology, Boris Adryan (Cambridge University) and Sarah Teichmann (LMB) have presented evidence that calls in to question currently-held beliefs about how transcription factors (TFs) coordinate gene expression during development to specify the fates of the different tissues in the body.” More…

Roger Williams elected as Academy of Medical Sciences Fellow

Published on 10 May, 2010

Dr Roger Williams, group leader in LMB’s PNAC Division, has been elected as a Fellow of the Academy of Medical Sciences. The Academy promotes the translation of advances in medical science into benefits for patients and the population at large: fellowship of the Academy is based on exceptional contributions to the medical sciences. Roger’s research […]

New endowed chair honors pioneering woman who ‘brought the fireworks’ to molecular biology

Published on 5 May, 2010

“On the night he learned he’d won the 1962 Nobel Prize, legend has it that DNA co-discoverer Francis Crick threw himself quite a party: angry neighbors, cops, the works. One of the guests, it seems, had brought a large supply of fireworks to the event, and the ensuing late-night mayhem was rocking the sleepy streets […]

Sarah Teichmann wins the 2011 Colworth Medal

Published on 30 April, 2010

Dr Sarah Teichmann has won the Biochemical Society’s 2011 Colworth Medal. The medal is awarded annually to a biochemist under the age of 35 for outstanding research achievement. The award was made in recognition of her groundbreaking work on elucidating principles of the evolution and dynamics of transcriptional regulatory networks and protein complexes. Sarah joins […]

Bicycle Therapeutics signs license agreement with EPFL and adds SR One and SVLS to Seed Syndicate

Published on 29 April, 2010

“Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the identification and optimisation of chemically constrained cyclic peptides with high target specificity and binding affinity, has signed a License agreement with the Ecole Polytechnique Federale de Lausanne (EPFL) in Lausanne, Switzerland and has secured additional seed funding from SR One, the […]

Cancer-causing viruses exploit genetic achilles heel, finds study

Published on 27 April, 2010

“Scientists say some viruses can turn cells into ‘viral hotels’ by exploiting tiny molecules derived from human DNA. The UK study [directed by Cancer Research UK and in collaboration with LMB] found that some viruses can boost microRNA activity to suppress the immune system’s reaction to them.” More…

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 313
  • Page 314
  • Page 315
  • Page 316
  • Page 317
  • Interim pages omitted …
  • Page 321
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.